Stay updated on Repeated QLT091001 Treatments in Retinal Diseases Clinical Trial
Sign up to get notified when there's something new on the Repeated QLT091001 Treatments in Retinal Diseases Clinical Trial page.

Latest updates to the Repeated QLT091001 Treatments in Retinal Diseases Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and the removal of detailed study information regarding the evaluation of QLT091001 for Leber Congenital Amaurosis (LCA).SummaryDifference25%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Repeated QLT091001 Treatments in Retinal Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repeated QLT091001 Treatments in Retinal Diseases Clinical Trial page.